One food, 108 trials: what garlic moved on blood pressure and cholesterol

Date:

Share this article:

Del denne artikel:

The largest garlic review yet pooled 108 randomized trials on more than 7,000 adults.

Daily garlic is linked to lower blood pressure, better cholesterol and calmer inflammation, according to the most comprehensive analysis of the evidence so far. Researchers pooled 108 randomized controlled trials with 7,137 adults, published in Nutrition Reviews in June 2025.

Across those trials, garlic supplementation lowered systolic blood pressure by an average of 3.71 mmHg and diastolic by 1.97 mmHg. Total cholesterol dropped by about 10.21 mg/dL, LDL by 5.90 mg/dL and triglycerides by 5.82 mg/dL. HDL, the "good" cholesterol, rose by 2.18 mg/dL.

The same pooled analysis also found lower fasting blood glucose (down 2.77 mg/dL), lower insulin and lower HOMA-IR, a common measure of insulin resistance.

Modest numbers, wide agreement

None of those shifts is large on its own. But the scale of the evidence is unusual.

Also read: Weight-loss drugs may slow cancer from spreading in the body, large data shows

Very few single foods have been studied in more than a hundred controlled trials, and the same direction of effect kept repeating across raw garlic, garlic powder, aged garlic extract and garlic oil.

A separate meta-analysis of long-term trials in hypertension, published in Frontiers in Nutrition in November 2025, pooled 10 trials on adults with high blood pressure. Systolic pressure fell by 4.21 mmHg and diastolic by 3.13 mmHg.

Significant reductions appeared in 8-week interventions and in people whose baseline systolic pressure sat between 130 and 149 mmHg.

How allicin gets to blood pressure

The active compound most often credited is allicin, which forms when raw garlic is crushed or chopped.

Also read: Adding one daily supplement to antidepressants may ease depression faster after 60

A 2024 review in Nutrients maps out the main pathways garlic uses to lower blood pressure. Chief among them is nitric oxide, a signaling molecule that relaxes blood vessel walls and lowers vascular resistance.

Garlic-derived compounds also inhibit angiotensin-converting enzyme, the same target as ACE inhibitor drugs, and generate hydrogen sulfide, another vasodilator. Together, those pathways match the modest blood pressure drops seen in the trials.

What a practical daily dose looks like

Most trials tested doses equivalent to one or two cloves of raw garlic a day, roughly 2 to 5 grams, whether given as fresh garlic, powder or aged extract. The effect appears across all of those forms.

There are limits. Garlic can raise the risk of bleeding, especially alongside warfarin, and it interacts with the HIV drug saquinavir as well as with several blood pressure medications.

Also read: A pancreatic cancer pill nearly doubled survival in trials. Its price: $480,000 a year

Anyone already on prescription drugs should check with a clinician before adding a daily garlic supplement.

Immunity and inflammation follow the same pattern

Two of the most watched markers of chronic inflammation shifted in the healthy direction across the 108 trials. C-reactive protein fell by 1.6 mg/L and TNF-alpha by 3.94 pg/mL, both statistically significant. A third marker, interleukin-6, did not change significantly.

Also read: How eating avocado every day affects your LDL cholesterol and heart risk

This article is made and published by Jesper Bengtson, who may have used AI in the preparation.

Other articles

Two drugs you may have in your medicine cabinet just entered an Alzheimer’s trial

Researchers want to shortcut a search that has moved painfully slowly for years, and they are starting with two surprisingly familiar medicines.

7 warning signs your vitamin D may be dropping as the days get shorter

The body makes most of its supply from the sun, and once October ends the pipeline largely shuts down across much of the country.

1 in 5 infants globally missed their first measles vaccine in 2023, and cases are up 40% since 2019

Decades of progress against childhood measles are slipping, and the gap begins before most babies take their first steps.

No approved drug exists for cocaine addiction, and the NIH just bet on a psychedelic

The treatment comes paired with its own kind of therapy, and it targets a pattern the two illnesses have in common.

Two drugs you may have in your medicine cabinet just entered an Alzheimer’s trial

Researchers want to shortcut a search that has moved painfully slowly for years, and they are starting with two surprisingly familiar medicines.

7 warning signs your vitamin D may be dropping as the days get shorter

The body makes most of its supply from the sun, and once October ends the pipeline largely shuts down across much of the country.

1 in 5 infants globally missed their first measles vaccine in 2023, and cases are up 40% since 2019

Decades of progress against childhood measles are slipping, and the gap begins before most babies take their first steps.